[go: up one dir, main page]

AU2002365083A1 - Composition and method to treat viral bacterial and parasitic infections and infestations - Google Patents

Composition and method to treat viral bacterial and parasitic infections and infestations

Info

Publication number
AU2002365083A1
AU2002365083A1 AU2002365083A AU2002365083A AU2002365083A1 AU 2002365083 A1 AU2002365083 A1 AU 2002365083A1 AU 2002365083 A AU2002365083 A AU 2002365083A AU 2002365083 A AU2002365083 A AU 2002365083A AU 2002365083 A1 AU2002365083 A1 AU 2002365083A1
Authority
AU
Australia
Prior art keywords
infestations
composition
parasitic infections
treat viral
viral bacterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002365083A
Other versions
AU2002365083A8 (en
Inventor
Stephen E. Bachman
Michael E. Hubbert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ganado Research LLC
Original Assignee
Ganado Research LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ganado Research LLC filed Critical Ganado Research LLC
Publication of AU2002365083A1 publication Critical patent/AU2002365083A1/en
Publication of AU2002365083A8 publication Critical patent/AU2002365083A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002365083A 2001-10-17 2002-10-17 Composition and method to treat viral bacterial and parasitic infections and infestations Abandoned AU2002365083A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32993701P 2001-10-17 2001-10-17
US60/329,937 2001-10-17
PCT/US2002/033060 WO2003051281A2 (en) 2001-10-17 2002-10-17 Composition and method to treat viral bacterial and parasitic infections and infestations

Publications (2)

Publication Number Publication Date
AU2002365083A1 true AU2002365083A1 (en) 2003-06-30
AU2002365083A8 AU2002365083A8 (en) 2003-06-30

Family

ID=23287659

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002365083A Abandoned AU2002365083A1 (en) 2001-10-17 2002-10-17 Composition and method to treat viral bacterial and parasitic infections and infestations

Country Status (2)

Country Link
AU (1) AU2002365083A1 (en)
WO (1) WO2003051281A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1322045C (en) * 2005-07-27 2007-06-20 丁宏广 Bactericidal enzyme agglomerate, bactericidal enzyme polymer monofilament and its preparing process and uses
DE102005051366A1 (en) * 2005-10-25 2007-04-26 Degussa Gmbh Drug delivery systems
US8445024B2 (en) 2005-10-25 2013-05-21 Evonik Degussa Gmbh Preparations containing hyperbranched polymers
IT1391170B1 (en) * 2008-08-07 2011-11-18 D M G Italia S R L INTRA-NASAL TOPIC COMPOSITION USABLE IN CASE OF NASAL OBSTRUCTION
US20130028882A1 (en) * 2011-07-07 2013-01-31 Humanitas Technology, LLC Antiviral compositions and methods of their use
US12447166B2 (en) 2016-02-25 2025-10-21 Applied Biological Laboratories, Inc. Compositions and methods for protecting against airborne pathogens and irritants
KR102844566B1 (en) * 2016-02-25 2025-08-08 어플라이드 바이올로지컬 래버러토리즈 인코포레이티드 Compositions and methods for protecting against airborne pathogens and irritants
WO2021142425A1 (en) * 2020-01-10 2021-07-15 Equilibre Neuroscience Ltd. Treatment of neurological disorders with avermectins

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5397771A (en) * 1990-05-10 1995-03-14 Bechgaard International Research And Development A/S Pharmaceutical preparation
WO1991016929A1 (en) * 1990-05-10 1991-11-14 Novo Nordisk A/S A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols
US6290991B1 (en) * 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same

Also Published As

Publication number Publication date
WO2003051281A2 (en) 2003-06-26
AU2002365083A8 (en) 2003-06-30
WO2003051281A3 (en) 2003-12-18

Similar Documents

Publication Publication Date Title
AU2002329884A1 (en) Processed soft tissue for topical or internal application
AU2003231866A1 (en) Herbs and herbal combinations useful for the treatment of microbial infections
WO2003088897A3 (en) Fab i inhibitors
WO2003010138A3 (en) Piperidine derivatives as antibacterial agents
AU2001268564A1 (en) Alpha-glycosylceramides for treating bacterial and fungal infections
AU2003901008A0 (en) Composition for the treatment and prevention of bacterial infections
AU2002232558A1 (en) Compounds, compositions and methods for treatment of parasitic infections
AU2003298662A1 (en) Dalbavancin compositions for treatment of bacterial infections
WO2003099217A3 (en) Methods of treating bacterial infections and diseases associated therewith
WO2002044989A8 (en) Method and system for dynamically maintaining internet associations
AU2002356868A1 (en) Methods for the prevention or treatment of bacterial and fungal infections
AU2002323270A1 (en) Composition and method for treating hiv infection
AU2001269704A1 (en) Oxazinoquinolones useful for the treatment of viral infections
AU2002364964A1 (en) Galliumcomplexes of 3-hydroxy-4-pyrones to treat mycobacterial infections
AU2002365083A1 (en) Composition and method to treat viral bacterial and parasitic infections and infestations
AU2002324753A1 (en) Composition and method for treating viral infection
AU2002359327A1 (en) Method of treating viral infections
AU2002353774A1 (en) Products and methods for treating microbial infections
AU2003259202A1 (en) Compositions and methods for treating and preventing infection
AU2002365168A1 (en) Method and composition for treating and preventing hiv infection and aids
AU2002334761A1 (en) Methods of treating drug-resistant bacterial infections
AU2003237088A1 (en) Compounds, compositions and methods for treating or preventing viral infections and associated diseases
AU2002333910A1 (en) Pharmaceutical composition for the treatment of viral, fungal and bacterial infections and applications of same
AU2003290506A1 (en) Methods and devices for treating severe peripheral bacterial infections
AU2003275069A1 (en) Compositions and methods for preventing infection

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase